17-31221930-G-T

Variant summary

Our verdict is Pathogenic. The variant received 24 ACMG points: 24P and 0B. PS1_Very_StrongPM1PM2PM5PP3_ModeratePP5_Very_Strong

The ENST00000431387.8(NF1):​c.1722G>T​(p.Arg574Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R574G) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NF1
ENST00000431387.8 missense

Scores

4
2
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 9.28

Publications

4 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 24 ACMG points.

PS1
Transcript ENST00000431387.8 (NF1) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in ClinVar.
PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 11 benign, 13 uncertain in ENST00000431387.8
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-31221928-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1778746.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 17-31221930-G-T is Pathogenic according to our data. Variant chr17-31221930-G-T is described in ClinVar as Pathogenic. ClinVar VariationId is 428975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000431387.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
NM_001042492.3
MANE Select
c.1721+1G>T
splice_donor intron
N/ANP_001035957.1
NF1
NM_001128147.3
c.1722G>Tp.Arg574Ser
missense
Exon 15 of 15NP_001121619.1
NF1
NM_000267.4
c.1721+1G>T
splice_donor intron
N/ANP_000258.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
ENST00000431387.8
TSL:1
c.1722G>Tp.Arg574Ser
missense
Exon 15 of 15ENSP00000412921.4
NF1
ENST00000358273.9
TSL:1 MANE Select
c.1721+1G>T
splice_donor intron
N/AENSP00000351015.4
NF1
ENST00000356175.7
TSL:1
c.1721+1G>T
splice_donor intron
N/AENSP00000348498.3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1438746
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
715416
African (AFR)
AF:
0.00
AC:
0
AN:
32576
American (AMR)
AF:
0.00
AC:
0
AN:
42156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25634
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39356
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81882
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48028
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4076
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1105578
Other (OTH)
AF:
0.00
AC:
0
AN:
59460
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neurofibromatosis, type 1 Pathogenic:2
Mar 15, 2022
Genome-Nilou Lab
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 07, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the c.1721+1 nucleotide in the NF1 gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 18546366, 23913538). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 428975). Disruption of this splice site has been observed in individual(s) with neurofibromatosis type 1 (NF1) (PMID: 23913538). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 15 of the NF1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538).

Hereditary cancer-predisposing syndrome Pathogenic:1
Sep 23, 2015
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1721+1G>T intronic pathogenic mutation results from a G to T substitution one nucleotide after coding exon 15 of the NF1 gene.<br /> This mutation was detected in an individual who met NIH diagnostic criteria for NF1 (Sabbagh A, et al.Hum. Mutat. 2013;34(11):1510-8).In addition to the clinical data presented in the literature, since alterations that disrupt the canonical splice donor site are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Pathogenic
0.43
D
BayesDel_noAF
Benign
-0.39
CADD
Pathogenic
31
DANN
Uncertain
0.99
Eigen
Uncertain
0.66
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Pathogenic
0.76
D
PhyloP100
9.3
ClinPred
0.99
D
GERP RS
5.8
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.87
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.87
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131691096; hg19: chr17-29548948; API